|
Smithkline Beecham obtains United States patent.(#6232441)(Brief Article)
From:
BIOTECH Patent News
| Date:
May 1, 2001
| COPYRIGHT 2001 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.Copyright information
|
Smithkline Beecham Corporation (Philadelphia, PA) has patented PIGR-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing PIGR-1 polypeptides and polynucle...
Related newspaper, magazine, and journal articles from HighBeam Research
|
|
Smithkline Beecham obtains United States patent.(SmithKline Beecham Corp.)(Brief Article)
BIOTECH Patent News
; Smithkline Beecham Corporation (Philadelphia, PA) has patented HNEAA81 polypeptides and polynucleotides, and methods for identifying agonists and antagonists of the interaction of the HNEAA81 receptor and its ligands in the design of protocols for the treatment of infections. (US 6162899)
|
|
|
Smithkline Beecham obtains United States patent.(HE8CH90 polypeptides and polynucleotides)(Brief Article)
BIOTECH Patent News
; Smithkline Beecham Corporation (Philadelphia, PA) has patented HE8CH90 polypeptides and polynucleotides and method, for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HE8CH90 polypeptides and polynucleotides in the design of protocols
|
|
|
Smithkline Beecham obtains United States patent.
BIOTECH Patent News
; Smithkline Beecham Corporation (Philadelphia, PA) has patented TR7 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques. Also disclosed are methods for utilizing TR7 polypeptides and polynucleotides in the design of protocols for the treatment of
|
|
|
SmithKline Beecham applies for patent.
BIOTECH Patent News
; SmithKline Beecham Corporation (London, United Kingdom) has applied for a patent covering AXOR14 polypeptides and polynucleotides useful for treating microbial infections, pain, cancers, and neurological disorders. (US Appl. 260298; WO Publication 200026339)
|
|
SmithKline Beecham to purchase block drug
Pharmaceutical Representative
; Philadelphia-based SmithKline Beecham and Jersey City, NJ-based Block Drug Co. Inc. announced that the companies have signed agreements for SmithKline Beecham to acquire Block Drug, the manufacturer of Sensodyne(R) toothpaste and various other oral healthcare and consumer products. The transaction,
|
